Table 1 Participant characteristics of lung cancer cases and controls in GWAS cohorts

From: Identification of susceptibility pathways for the role of chromosome 15q25.1 in modifying lung cancer risk

Variants

1st Discovery cohort (n = 3900)

2nd Discovery cohort (n = 6573)

Replication Cohort (n = 32,465)

 

Control (n = 1977)

Case (n = 1923)

P-value

Control (n = 3578)

Case (n = 2995)

P-value

Control (n = 14,026)

Case (n = 18,439)

P-value

 

No.

%

No.

%

 

No.

%

No.

%

 

No.

%

No.

%

 

Age (years)

               

 0–64

502

25.4

420

21.8

0.009

2304

64.39

1825

60.9

0.004

8449

60.2

9513

51.6

<0.0001

 ≥65

1475

74.6

1503

78.2

1274

35.61

1170

39.1

5577

39.8

8926

48.4

 

Gender

               

 Male

1514

76.6

1520

79.0

0.06

2417

67.55

2093

69.9

0.04

8639

61.6

11,495

62.3

0.37

 Female

463

23.4

403

21.0

 

1161

32.45

902

30.1

 

5384

38.4

6941

37.6

 

 Omitted

          

3

0.02

3

0.02

 

Smoking status

               

  Never

633

32.0

138

7.1

<0.0001

867

24.23

137

4.6

<0.0001

4415

31.5

1800

9.8

<0.0001

  Ever

1339

67.7

1774

92.3

 

2702

75.52

2854

95.3

 

9930

66.5

16,341

88.6

 

  Omitted

5

0.3

11

0.6

 

9

0.25

4

0.1

 

281

2.0

298

1.6

 

Histology

               

  Squamous

  

488

25.4

   

307

10.3

   

4490

24.3

 

  Adenocarcinoma

  

788

40.9

   

620

20.7

   

6819

37.0

 

  Other

  

613

31.9

   

226

7.5

   

5487

29.8

 

  Omitted

  

34

1.8

   

1842

61.5

   

1643

8.9